Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloproliferative Disorders | 9 | 2024 | 616 | 4.040 |
Why?
|
Thrombocythemia, Essential | 5 | 2024 | 114 | 3.590 |
Why?
|
Polycythemia Vera | 6 | 2023 | 160 | 3.120 |
Why?
|
Primary Myelofibrosis | 3 | 2023 | 208 | 1.540 |
Why?
|
Thrombocytosis | 2 | 2024 | 88 | 1.140 |
Why?
|
Janus Kinase 2 | 4 | 2023 | 561 | 0.900 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2021 | 184 | 0.770 |
Why?
|
Blast Crisis | 1 | 2021 | 102 | 0.750 |
Why?
|
Venous Thromboembolism | 3 | 2023 | 1883 | 0.680 |
Why?
|
Calreticulin | 1 | 2019 | 115 | 0.620 |
Why?
|
Plasmacytoma | 1 | 2019 | 170 | 0.610 |
Why?
|
Splanchnic Circulation | 1 | 2017 | 122 | 0.560 |
Why?
|
Live Birth | 1 | 2020 | 516 | 0.550 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 686 | 0.550 |
Why?
|
Meningeal Carcinomatosis | 1 | 2017 | 65 | 0.530 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2016 | 50 | 0.520 |
Why?
|
Skull Base Neoplasms | 1 | 2019 | 279 | 0.500 |
Why?
|
Abortion, Spontaneous | 1 | 2020 | 534 | 0.500 |
Why?
|
Food Microbiology | 1 | 2015 | 73 | 0.480 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3626 | 0.460 |
Why?
|
Acid Phosphatase | 1 | 2014 | 141 | 0.450 |
Why?
|
Listeriosis | 1 | 2015 | 147 | 0.440 |
Why?
|
Hemorrhage | 2 | 2024 | 3464 | 0.430 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2016 | 645 | 0.410 |
Why?
|
Remission Induction | 1 | 2018 | 2408 | 0.410 |
Why?
|
Hematologic Neoplasms | 2 | 2021 | 1907 | 0.410 |
Why?
|
Peritonitis | 1 | 2015 | 368 | 0.400 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5716 | 0.380 |
Why?
|
Janus Kinases | 2 | 2023 | 253 | 0.350 |
Why?
|
Platelet Count | 2 | 2024 | 784 | 0.340 |
Why?
|
Methotrexate | 1 | 2016 | 1718 | 0.340 |
Why?
|
Fruit | 1 | 2015 | 1165 | 0.320 |
Why?
|
Isoenzymes | 1 | 2014 | 1688 | 0.320 |
Why?
|
Venous Thrombosis | 1 | 2017 | 1321 | 0.290 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3599 | 0.290 |
Why?
|
Tissue Donors | 1 | 2017 | 2387 | 0.270 |
Why?
|
Anticoagulants | 2 | 2023 | 4854 | 0.270 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 1433 | 0.270 |
Why?
|
Neoplasms | 4 | 2023 | 22350 | 0.250 |
Why?
|
Thrombosis | 3 | 2024 | 2954 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11872 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5693 | 0.240 |
Why?
|
Models, Biological | 1 | 2020 | 9464 | 0.230 |
Why?
|
Mutation | 4 | 2023 | 30211 | 0.220 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10254 | 0.220 |
Why?
|
Disease Management | 3 | 2024 | 2531 | 0.210 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2024 | 260 | 0.200 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2535 | 0.190 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5186 | 0.180 |
Why?
|
Biology | 1 | 2023 | 292 | 0.180 |
Why?
|
Cyclophosphamide | 2 | 2017 | 2227 | 0.180 |
Why?
|
Phlebotomy | 1 | 2021 | 138 | 0.180 |
Why?
|
Humans | 27 | 2024 | 767040 | 0.170 |
Why?
|
STAT Transcription Factors | 1 | 2019 | 189 | 0.160 |
Why?
|
Macrophages | 1 | 2014 | 5785 | 0.160 |
Why?
|
Interferons | 1 | 2022 | 716 | 0.150 |
Why?
|
Receptors, Thrombopoietin | 1 | 2019 | 159 | 0.150 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5389 | 0.150 |
Why?
|
Aged | 11 | 2024 | 171319 | 0.150 |
Why?
|
Female | 15 | 2024 | 396660 | 0.140 |
Why?
|
Drug Dosage Calculations | 1 | 2017 | 116 | 0.130 |
Why?
|
Signal Transduction | 1 | 2019 | 23621 | 0.130 |
Why?
|
Adult | 10 | 2024 | 223317 | 0.130 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6360 | 0.130 |
Why?
|
Pregnancy | 3 | 2024 | 30238 | 0.130 |
Why?
|
Middle Aged | 10 | 2024 | 223233 | 0.130 |
Why?
|
Histocompatibility | 1 | 2017 | 322 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20741 | 0.130 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9108 | 0.120 |
Why?
|
Disease Progression | 2 | 2023 | 13646 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36582 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1472 | 0.120 |
Why?
|
Vincristine | 1 | 2016 | 1040 | 0.110 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2972 | 0.110 |
Why?
|
Administration, Oral | 1 | 2021 | 4026 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 696 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1012 | 0.110 |
Why?
|
Male | 12 | 2024 | 364203 | 0.100 |
Why?
|
Listeria monocytogenes | 1 | 2015 | 246 | 0.100 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 281 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13491 | 0.100 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 545 | 0.100 |
Why?
|
Prednisone | 1 | 2016 | 1566 | 0.100 |
Why?
|
Retrospective Studies | 4 | 2024 | 81659 | 0.100 |
Why?
|
Risk Factors | 4 | 2024 | 74886 | 0.090 |
Why?
|
Drug Resistance | 1 | 2017 | 1592 | 0.090 |
Why?
|
Gene Frequency | 1 | 2017 | 3621 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3212 | 0.090 |
Why?
|
Prognosis | 3 | 2020 | 29963 | 0.090 |
Why?
|
Pituitary-Adrenal System | 1 | 2013 | 555 | 0.080 |
Why?
|
Doxorubicin | 1 | 2016 | 2229 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4838 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3944 | 0.080 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3434 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2764 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2013 | 703 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9551 | 0.070 |
Why?
|
Growth Inhibitors | 1 | 2008 | 375 | 0.070 |
Why?
|
Incidence | 1 | 2024 | 21526 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2013 | 1407 | 0.060 |
Why?
|
Young Adult | 3 | 2018 | 59980 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10393 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2017 | 65295 | 0.060 |
Why?
|
Melanocytes | 1 | 2008 | 509 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5180 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59548 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2815 | 0.060 |
Why?
|
Social Class | 1 | 2013 | 2007 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2015 | 1959 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10092 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3049 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18401 | 0.050 |
Why?
|
Antigens, CD | 1 | 2014 | 4032 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2008 | 845 | 0.050 |
Why?
|
Genomics | 1 | 2019 | 5924 | 0.050 |
Why?
|
Mothers | 1 | 2013 | 2209 | 0.050 |
Why?
|
Hydroxyurea | 1 | 2023 | 284 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9746 | 0.050 |
Why?
|
Hippocampus | 1 | 2013 | 3777 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1995 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22254 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2023 | 909 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15645 | 0.040 |
Why?
|
Animals | 2 | 2021 | 168965 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2024 | 1791 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2008 | 4925 | 0.030 |
Why?
|
Mice | 1 | 2019 | 81912 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2013 | 504 | 0.020 |
Why?
|
Association Learning | 1 | 2013 | 219 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3883 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27163 | 0.020 |
Why?
|
Melanoma | 1 | 2008 | 5702 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3283 | 0.020 |
Why?
|
Saliva | 1 | 2013 | 853 | 0.020 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2008 | 110 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2008 | 168 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2008 | 899 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2013 | 1840 | 0.020 |
Why?
|
Adenoviridae | 1 | 2008 | 1092 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6331 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 24299 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1646 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3611 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4143 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41718 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39317 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54886 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5203 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10455 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 17097 | 0.010 |
Why?
|
Child | 1 | 2013 | 80771 | 0.000 |
Why?
|
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_